Trusted by communications, security, and research teams
Adverse event signals surface here — in real time
This is the signal monitor your pharmacovigilance team would use. Cross-platform patient signals, adverse event flags, and live signal velocity — all in one view.
Ask a question. Get a structured investigation.
The Rolli IQ Agent plans its own analysis, scans 8+ platforms, scores every signal for authenticity, and delivers a structured brief with recommendations — not just data.
Set it. Forget it. Get briefed.
Schedule the Agent to run daily, weekly, or on any custom cadence. Briefs land in your inbox or Slack — structured, scored, and ready to act on.
Any cadence you choose
Daily morning briefs, weekly narrative recaps, monthly trend summaries — or a fully custom schedule. You control the frequency.
Email or Slack delivery
Briefs land directly in your team’s inbox or a dedicated Slack channel — formatted, structured, and ready to forward to leadership.
Same depth as on-demand
Every scheduled brief is a full investigation: authenticity scoring, coordination detection, and a recommendation — not just a keyword summary.
Why your drug launch monitoring has gaps
Three types of coordinated narrative campaigns targeting pharmaceutical companies. One platform to detect them all.
Setup in under 10 minutes
Respond before the narrative becomes a headline
What happens from sentiment shift to response
Three pharma scenarios. Same problem. Rolli solves all of them.
Drug launch monitoring
Before Rolli: Your team tracks drug launch conversations with broad keyword searches that miss nuance in patient discussions. Thousands of social signals go unstructured and unscored during the critical first 72 hours.
With Rolli: Real-time cross-platform sentiment with authenticity scoring from minute one. Your medical affairs team sees structured patient reaction data across all platforms during the launch window.
Pharmacovigilance signal detection
Before Rolli: Patients discuss adverse events, side effects, and drug interactions on Reddit, X, and Facebook groups for months before formal reports reach FAERS. Your pharmacovigilance team sees them last.
With Rolli: Structured social signals surface adverse event discussions in real time — timestamped, sourced, and scored for authenticity. Your team triages signals months before they appear in formal reporting systems.
Anti-pharma campaign defense
Before Rolli: Coordinated anti-vax and anti-pharma campaigns look identical to genuine patient concern. Your monitoring tools can't tell the difference, flooding your team with noise.
With Rolli: Authenticity scoring separates genuine patient advocacy from manufactured anti-pharma amplification — giving your comms and medical affairs teams clear signal for response prioritization.
Ready to detect your first coordinated campaign?
Financial services teams are live in under 2 hours. No long onboarding.
What healthcare & pharma leaders say
Enterprise security review available
SOC 2 Type II certification in progress (Q3 2026). In the meantime, we offer:
- Completed security questionnaire (CAIQ)
- Available for pen-test coordination
- NDA-protected architecture review
This is what an adverse event signal looks like in Rolli IQ
A real-time intelligence alert your pharmacovigilance team would receive — with verified patient signals, not raw social noise.
Simulated alert — based on real detection patterns. Authenticity scores and cluster data are representative examples.
Common questions
Research on social media and pharmacovigilance
Regulatory agencies increasingly recognize social media as a source of pharmacovigilance signals. See how Rolli approaches this challenge in our influence operation detection overview.
Also for
Intelligence for every team that needs the truth
Security & Trust Safety
Detect coordinated threats before they scale
Flag influence operations, synthetic amplification, and platform manipulation hours before mainstream pickup.
Communications & PR
Brief leadership on verified signal, not noise
Separate organic spikes from manufactured amplification and brief executives in minutes.